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Abstract
Background: Epidemiological evidence indicates a protective effect of light-moderate drinking on cardiovascular
disease and an increased risk for heavier drinking. Nevertheless, the effect of alcohol on atherosclerotic changes in
vessel walls is disputed. Most previous studies have only looked at the cross-sectional relationship between alcohol
and carotid intima media thickness (cIMT) – a surrogate marker of atherosclerosis. Single measurements of alcohol
assume that alcohol exposure is stable and ignore the possible cumulative effects of harm, leading to possibly
incorrect inferences.
Methods: Data were retrieved from two UK population based cohort studies: the Whitehall II cohort of civil servants
and the MRC National Survey of Health and Development (combined sample size of 5403 men and women).
Twenty year-drinking trajectories during midlife were linked to measures of cIMT when participants were in early old
age, and adjusted for age, sex, socioeconomic position, ethnicity and smoking.
Results: Those who consistently drank heavily had an increased cIMT compared to stable moderate drinkers
(pooled difference in cIMT 0.021 mm; 95 % CI 0.002 to 0.039), after adjustment for covariates. This was not detected in
cross-sectional analyses. Former drinkers also had an increased cIMT compared to moderate drinkers (pooled difference
in cIMT 0.021; 95 % CI 0.005 to 0.037). There were no appreciable differences in cIMT between non-drinkers and
consistent moderate drinkers.
Conclusion: The drinking habits among adults during midlife affect the atherosclerotic process and sustained
heavy drinking is associated with an increased cIMT compared to stable moderate drinkers. This finding was not
seen when only using cross-sectional analyses, thus highlighting the importance of taking a life course approach.
There was no evidence of a favourable atherosclerotic profile from stable moderate drinking compared to stable
non-drinking.
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Background
Alcohol consumption is one of the biggest public health
challenges facing modern society and is ranked as the
world’s third largest risk factor for disease burden [1].
There are also currently concerns about the long-term
ill health effects of the drinking habits of middle-aged
adults, a group who have been described as ‘hidden’
risky drinkers [2].
Epidemiological evidence indicates a protective effect
of light-moderate alcohol consumption on cardiovascu-
lar morbidity and mortality compared to non-drinking
and an increased risk of cardiovascular events amongst
heavier drinkers [3–5]. The endpoint of cardiovascular
disease (CVD) often occurs later in life; the extent to
which alcohol consumption earlier in the life course is
implicated in the process is less clear. As yet, the bio-
logical mechanisms underlying the association between
alcohol intake and CVD are not fully elucidated, and it
has been argued that the protective effect observed in
observational studies may, in part, be due to misclassifi-
cation errors and reporting biases [6]. If the cardiovas-
cular benefits of moderate alcohol consumption are
genuine, they may be explained in part by alcohol’s in-
fluence on serum lipids [7] and other cardiovascular
biomarkers [8], blood pressure, and atherosclerosis [9].
Nevertheless, the effect of alcohol on atherosclerotic
changes in vessel walls is disputed. Carotid intima
media thickness (cIMT) is an intermediate phenotype
of early atherosclerosis or a marker of subclinical organ
damage that independently predicts vascular events
[10]. Some studies have found evidence of a reduced
risk of atherosclerosis (as measured by cIMT) in mod-
erate drinkers [11–17], while others report no associ-
ation [18–21], or an increased risk [22–24]. Most of the
previous studies have only looked at the cross-sectional
association between alcohol intake and cIMT. Single ob-
servations of alcohol consumption assume that drinking is
a stable behaviour. However, there is evidence from de-
scriptive studies that individuals change their alcohol
consumption levels over time [25, 26]. Research on the
health consequences of alcohol, therefore, needs to ad-
dress the effects of changes in drinking behaviour over
the life course [27]. Failure to include such dynamics
can lead to incorrect inferences about the effects of al-
cohol on chronic disease risk [28].
In this paper we sought to (1) describe trajectories of
alcohol consumption during midlife, (2) link these tra-
jectories to risk of atherosclerosis, as measured by cIMT
in early old-age, and (3) compare these associations with
cross-sectional findings in the same cohorts.
Methods
Data were drawn from two UK population-based co-
horts: the Whitehall II Cohort of British Civil Servants
and the MRC National Survey of Health and Develop-
ment (NSHD). In both cohorts, alcohol consumption
was self-reported at four time points over a 20-year
period and cIMT was measured when participants were
in early old-age (50–74 years).
Whitehall II study
The Whitehall II study was established in 1985 as a
longitudinal study to examine the socioeconomic gradi-
ent in health and disease among 10,308 civil servants
(6895 men and 3413 women) [29]. All civil servants
aged 35–55 years in 20 London-based departments
were invited to participate by letter and 73 % agreed.
Baseline examination (Phase 1) took place during
1985–1988, and involved a clinical examination and a
self-administered questionnaire containing sections on
demographic characteristics, health, lifestyle factors,
work characteristics, social support and life events.
The clinical examination included measures of blood
pressure, anthropometry, biochemical measurements,
neuroendocrine function, and subclinical markers of
cardiovascular disease. Subsequent phases of data col-
lection have alternated between postal questionnaire
alone and postal questionnaire accompanied by a clin-
ical examination. Data used in the analyses came from
phases 1 (1985–1988), 3 (1991–1994), 5 (1997–1999)
and 7 (2002–2004) of the study.
From the 10,308 participants at baseline, 3321 did not
participate in phase 7 (584 died, 2757 withdrew or did
not respond). Of the eligible 6967, 4109 (59 %) had a
valid measure of cIMT. A further 49 people were miss-
ing age or alcohol data and 20 were missing information
on socioeconomic position (SEP) and/or smoking.
The University College London Medical School
Committee on the ethics of human research approved
the Whitehall II study. Written informed consent was
obtained at baseline and renewed at each contact.
Whitehall II data, protocols and other metadata are avail-
able to bona fide researchers for research purposes (the
data sharing policy is available at http://www.ucl.ac.uk/
whitehallII/data-sharing).
NSHD
The NSHD is a nationally representative sample of 5362
singleton births to married parents in England, Scotland
and Wales, stratified by social class in 1 week in March
1946 in Britain. The sample has been followed-up 24
times since birth to age 60–64 years [30]; the 25th
follow-up at 68–69 years is ongoing. The study protocol
received ethical approval from the Central Manchester
Research Ethics Committee for a clinic data collection
taking place in Manchester, Birmingham, Cardiff and
London at 60–64 years. Ethical permission was given by
the Scotland A Research Ethics Committee for the data
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collection taking place in Edinburgh. Written informed
consent was obtained from the study member at each
stage of data collection. Bona fide researchers can apply to
access the NSHD data via a standard application procedure
(further details available at: http://www.nshd.mrc.ac.uk/
data.aspx).
At the clinical follow-up, when study members were
aged between 60 and 64 years, 2856 of those still alive
and with a known current address in mainland Britain
were invited for assessment at one of six clinical re-
search facilities; those unable or unwilling to travel were
offered a home visit by a research nurse [30]. Of those
invited, a total 2229 participants (78 %) underwent as-
sessment: 1690 attended a clinical research facility and
the remaining 539 were seen in their homes [31]; 1532
participants had a valid measure of cIMT (62 % of eli-
gible). A further 151 had missing alcohol or age and 131
missing information on SEP and/or smoking.
Therefore, our analyses are based on 4060 Whitehall II
participants and 1391 NSHD participants with valid
cIMT and repeat alcohol data. We used modified Pois-
son regression [32] to compare baseline characteristics
of those excluded and included in the analysis, and
found those included were more likely to be of higher
SEP, moderate drinkers and never smokers.
Alcohol consumption
In both cohorts, alcohol measurements were available
at four time points over a 20-year period before the
measurement of cIMT, at roughly comparable ages. In
Whitehall II, at phases 1, 3, 5 and 7, participants were
asked to report the number of alcoholic drinks they
had consumed in the last 7 days. Drinks were converted
into UK units of alcohol (whereby one unit is equiva-
lent to 8 g of ethanol) using a conservative estimate of
one UK unit for each measure of spirits and glass of
wine, and two UK units for each pint of beer. These
converted measurements were then summed to define
the total weekly number of UK units consumed.
In NSHD, at ages 36, 43, 53 and 60–64, alcohol con-
sumption was assessed using a 5-day food diary. From
these diaries, an estimate was derived of total alcohol
consumed per week in UK units. Further details on har-
monisation of alcohol consumption in these cohorts can
be found elsewhere [26].
Categories of alcohol consumption were then created
based on existing UK guidelines for sensible drinking at
the time of data collection [33], these were: none, “mod-
erate” (within guidelines (1–14 [8–112 g] units per week
for women, 1–21 [8–168 g] units per week for men)),
and “heavy” (above guidelines (15+ units for women, 22
+ units for men)). Trajectories of alcohol consumption
over the four measurement periods were then classified
as (1) stable none, (2) stable moderate, (3) stable heavy,
(4) mostly moderate (majority of phases were moderate),
and (5) mostly heavy or as (6) former drinkers (previ-
ously reported consumption but none in the most recent
phase). When an individual reported moderate and
heavy on an equal number of occasions, participants
were assigned to the mostly heavy drinking group. Indi-
viduals drinking at the cIMT assessment phase but not
at other occasions were classified as mostly moderate or
heavy on the basis of their drinking at the time. Partici-
pants were permitted one missing alcohol value during
follow-up.
Carotid IMT
At phase 7 in the Whitehall II study, when participants
were aged 50–74 years old (mean age 61 years), ultra-
sound vascular measures were performed at the Vascular
Physiology Unit, Institute of Child Health, London, UK.
Measurements were taken using the Aloka 5500 with a
7.5 MHz transducer. IMT was measured in the right and
left common carotid arteries. Longitudinal images of the
common carotid artery, triggered on the R-wave of the
ECG, were magnified and recorded in DICOM format as
a cine-loop on the hard drive of the ultrasound machine
for later analysis. The common carotid IMT was mea-
sured at its thickest part 1 cm proximal to the bifur-
cation. A measurement was taken between the leading
edge of the intima and the media adventitia on three
separate images on each side using electronic callipers
and the mean of the six measures was used for analysis.
At age 60–64 years in NSHD, cIMT was imaged longi-
tudinally in the right and left common carotid arteries,
1 cm proximal to the bifurcation. Measures were made
with the Vivid I ultrasound scanner (GE Healthcare;
Chalfont St Giles, UK) with a high resolution probe
(12 MHz). Ten second cine-loops were recorded in
DICOM format and downloaded for offline analysis.
Analysis of the cine-loops was performed at the same
Vascular Physiology Unit as for the Whitehall II study.
Three end-diastolic frames from each lateral view were
selected and the mean of the six measures used for
analysis.
Covariates
Covariates included age, sex, ethnicity, smoking status
and SEP. Smoking status (never, ex, current 0–10, 11+
cigarettes per day) and SEP (defined using last known
employment grade as high, intermediate and low in
Whitehall II and based on last known registrar general
social class in NSHD – categories 1 and 2: highest; 3
and 4: intermediate; 5 and 6: lowest) were identified from
self-reported questionnaires completed at the time of
cIMT measurement. Ethnicity was only available for the
Whitehall II cohort (white and non-white). The NSHD
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participants are all white as they were born in Britain be-
fore the start of mass immigration into the country.
Analysis
Quantile regression was used for the analysis as cIMT
measurements were mildly skewed [34]. In preliminary
analyses we found no significant effect modification by
sex so data were therefore pooled and adjustment made
for sex. We performed two stages of adjustment, firstly
for age and sex and secondly for age, sex, SEP, smoking
and ethnicity (in Whitehall II). We performed analyses
separately for each cohort and then combined estimates
from each study using random-effects meta-analysis.
Those with existing coronary heart disease (CHD)
(validated events) and/or type 2 diabetes (cases defined
using oral glucose tolerance tests, HbA1c values and/or
use of diabetes medication) were excluded in sensitivity
analyses using Whitehall II data (n = 1,501) to assess the
potential impact on overall findings if those with known
disease had changed their alcohol consumption in re-
sponse to disease onset. All analyses were performed
using Stata 14 from August to September 2015.
Results
The most common derived alcohol trajectories were
“stable moderate” (39.8 % Whitehall, 34.4 % NSHD) and
“mostly moderate” (24.9 % Whitehall, 31.3 % NSHD)
(Table 1). Smaller groups were “stable none” (5.3 %
Whitehall II, 4.5 % NSHD) and “stable heavy” (6.8 %
Whitehall II, 3.5 % NSHD). “Stable heavy” drinkers were
more likely to be male, current smokers and of white eth-
nicity (in Whitehall II) (Table 1). “Stable none” drinkers
were more likely to be female, non-smokers, of lower SEP
and non-white. The median cIMT level measured in the
overall Whitehall participant cohort was 0.77 mm (IQR
0.68–0.87), and 0.77 mm (IQR 0.68–0.88) for men and
0.77 mm (IQR 0.68–0.85) for women. The median lateral
view cIMT was 0.67 mm (IQR 0.60–0.76) in the NSHD
overall cohort, and 0.68 mm (IQR 0.61–0.79) for men and
0.66 mm (IQR 0.59–0.73) for women.
Cross-sectional analyses showed slightly elevated cIMT
values amongst non-drinkers (pooled β = 0.012 mm,
95 % CI –0.001 to 0.026) compared to moderate
drinkers (Fig. 1). When non-drinkers were separated
into former drinkers and never drinkers, the cIMT was
higher in former drinkers than never drinkers (available
in Additional file 1: Figure S1). In cross-sectional ana-
lyses there was little difference in atherosclerotic thick-
ening between heavy and moderate drinkers (pooled β
= 0.006 mm, 95 % CI –0.005 to 0.017) (Fig. 1).
The association between trajectories of drinking dur-
ing midlife and cIMT are shown in Fig. 2. Full results
from regression analyses are shown in Additional file 2:
Table S1 and S2. “Stable heavy” drinkers over the
20-year measurement period had elevated cIMT com-
pared to “stable moderate” drinkers (pooled difference of
0.021 mm, 95 % CI 0.002 to 0.039), after adjustment for
covariates. There were no appreciable differences between
“stable non-drinkers” and “stable moderate” drinkers
(pooled β = 0.008 mm, 95 % CI –0.003 to 0.018). “Former
drinkers” had raised cIMT (pooled β = 0.021 mm, 95 % CI
0.005 to 0.037). Mostly moderate and mostly heavy were
similar. Excluding those with prevalent CHD/diabetes in
the Whitehall II cohort did not substantially alter the esti-
mates (Additional file 1: Figure S2).
Discussion
We derived 20-year drinking trajectories during midlife
in two separate British population-based cohort studies
and linked these to cIMT in early old age. We found evi-
dence to suggest that former drinkers and those with
sustained heavy drinking during midlife had greater
cIMT values than stable moderate drinkers. We also ob-
served that stable moderate drinkers did not have re-
duced cIMT values compared to stable non-drinkers.
Combined, these findings indicate that midlife drinking
habits affect the atherosclerotic process.
The risks associated with heavy drinking in midlife
were only appreciable when considering a 20-year trajec-
tory of drinking and not in cross-sectional analyses. This
highlights the need to take a life course approach and
our study should be replicated with other outcomes.
Our data start from around age 35 years. Others have
suggested that an adverse effect on atherogenesis from
drinking may occur even earlier in life. In a cohort of
young Finns, aged 24–39 years, there was a dose–re-
sponse relationship between alcohol consumption and
increased cIMT [23].
However, there is a risk of misclassification if only
one measure of alcohol is considered. For example, we
found that, when current non-drinkers were separated
into former drinkers and never drinkers, the median
cIMT levels were substantially higher in the former
drinkers. Former drinkers may include individuals who ex-
perienced ill-health (including increased vascular problems
as indicated by higher cIMT) and subsequently quit. This
concurs with the well-known ‘sick-quitter’ phenomenon
whereby former drinkers who become ill and cease drink-
ing are classified as non-drinkers and this can erroneously
lead to suggested protective effects of drinking com-
pared to not drinking [35]. Alcohol consumption is not
a stable phenomenon over the life course. Exposure
varies, as shown in this paper by the large proportion
in both cohorts who did not have stable drinking trajec-
tories over the 20 years, and, elsewhere, we have shown
how mean consumption and frequency changes in these
cohorts and others [26].
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Table 1 Characteristics of participants by alcohol trajectories in Whitehall II and NSHD
Alcohol trajectories over previous 20 years Total
Stable none
(n, %)
Stable moderate drinker
(n, %)
Stable heavy drinker
(n, %)
Mostly moderate
(n, %)
Mostly heavy
(n, %)
Former drinker
(n, %)
Whitehall II Total 216 (5.3) 1615 (39.8) 274 (6.8) 1010 (24.9) 536 (13.2) 409 (10.1) 4060 (100)
Mean age, years (SD) 61.6 (6.3) 61.4 (5.9) 60.0 (5.4) 60.8 (5.8) 60.7 (5.79) 61.5 (6.0) 61.1 (5.9)
Median cIMT, mm (IQR) 0.78 (0.70–0.90) 0.77 (0.68–0.87) 0.77 (0.70–0.88) 0.77 (0.68–0.87) 0.87 (0.70–0.90 0.78 (0.70–0.87) 0.77 (0.68–0.87)
Male 96 (44.4) 1234 (76.4) 233 (85) 703 (69.6) 437 (81.5) 211 (51.6) 2914 (71.8)
Female 120 (55.5) 381 (23.6) 41 (15) 307 (30.4) 99 (18.5) 198 (48.4) 1146 (28.2)
Smoking: Never 155 (72.1) 883 (54.8) 87 (31.8) 501 (50.9) 198 (37.1) 210 (51.6) 2043 (50.6)
Ex-smoker 47 (21.9) 646 (40.1) 145 (52.9) 429 (42.9) 294 (55.2) 159 (39.1) 1720 (42.6)
Current 1–10 cpd 8 (3.7) 46 (2.9) 14 (5.1) 21 (2.1) 16 (3.0) 21 (5.2) 126 (3.1)
Current 11+ cpd 5 (2.3) 35 (2.2) 28 (10.2) 41 (4.1) 25 (4.7) 17 (4.2) 151 (3.7)
SEP: High 35 (16.2) 858 (53.1) 159 (58.0) 441 (43.7) 302 (56.3) 93 (22.7) 1881 (46.3)
Intermediate 107 (49.5) 648 (40.1) 111 (40.5) 473 (46.8) 215 (40.1) 210 (51.3) 1768 (43.5)
Low 74 (34.3) 109 (6.7) 4 (1.5) 96 (9.5) 19 (3.5) 106 (25.9) 411 (10.1)
White 132 (61.1) 1516 (93.9) 270 (98.5) 934 (92.5) 522 (97.4) 340 (83.1) 3715 (91.5)
Non-white 84 (38.9) 99 (6.1) 4 (1.5) 76 (7.5) 14 (2.6) 69 (16.9) 342 (8.5)
NSHD Total 62 (4.5) 478 (34.4) 49 (3.5) 436 (31.3) 181 (13.0) 185 (13.3) 1391 (100)
Mean age, years (SD) 63.2 (1.03) 63.3 (1.12) 63.2 (1.17) 63.2 (1.16) 63.2 (1.20) 63.4 (0.99) 63.3 (1.12)
Median cIMT, mm (IQR) 0.63 (0.57–0.76) 0.66 (0.60–0.75) 0.68 (0.62–0.80) 0.67 (0.59–0.75) 0.67 (0.59–0.77) 0.68 (0.61–0.76) 0.67 (0.60–0.76)
Male 16 (25.8) 230 (48.1) 43 (87.8) 207 (47.5) 112 (61.9) 65 (35.1) 673 (48.4)
Female 46 (74.2) 248 (51.9) 6 (12.2) 229 (52.5) 69 (38.1) 120 (64.9) 718 (51.6)
Smoking: Never 31 (55.4) 180 (40.2) 4 (9.3) 129 (31.8) 38 (22.4) 59 (34.9) 441 (34.1)
Ex-smoker 19 (33.9) 242 (54.0) 33 (76.7) 248 (61.1) 106 (62.4) 92 (54.4) 740 (57.3)
Current 1–10 cpd 5 (8.9) 11 (2.5) 1 (2.3) 8 (2.0) 9 (5.3) 6 (3.6) 40 (3.1)
Current 11+ cpd 1 (1.8) 15 (3.3) 5 (11.6) 21 (5.2) 17 (10.0) 12 (7.1) 71 (5.5)
SEP: High 20 (36.4) 263 (59.2) 26 (57.8) 227 (56.8) 104 (61.9) 73 (44.5) 713 (55.9)
Intermediate 21 (38.2) 158 (35.6) 14 (31.1) 131 (32.8) 52 (31.0) 70 (42.7) 446 (35.0)
Low 55 (25.5) 23 (5.2) 5 (11.1) 42 (10.5) 12 (7.1) 21 (12.8) 117 (9.2)
SEP Socioeconomic position, cIMT Carotid intima media thickness, SD Standard Deviation, IQR Interquartile range, cpd Cigarettes per day
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Much of the existing literature uses data with alcohol
exposure measured at a single time-point and takes a
mixed group of “non-drinkers” as the reference group.
Ours is the first study to look at trajectories of alcohol
and risk of cIMT, which makes drawing comparisons be-
tween our work and others difficult. Our cross-sectional
findings concur with those from the Atherosclerosis Risk
in Communities study and the National Heart, Lung,
and Blood Institute Family Heart Study, which indicate
no association between current alcohol intake and ca-
rotid artery wall thickness [18, 19]. Likewise, data from
over 6000 men and women in three French cities
showed no marked relationship of alcohol and cIMT
[20]. Others have found a U-shaped relationship be-
tween alcohol and cIMT in cross-sectional analyses. In
the Cardiovascular Health Study investigating subjects
over 65 years, consumers of 1–6 drinks per week (equal-
ling < 15 g/d) had a cIMT 0.07 mm lower than ab-
stainers, whereas consumers of 14 or more drinks
(equalling > 30 g/d) had an IMT 0.07 mm higher than
abstainers. Like in the present study, they found that
former drinkers had an increased cIMT [16].
Our trajectory work suggests that clinicians need to
place emphasis on drinking histories as well as current
drinking behaviour. Attempting to quantify the effect of
heavy drinking on atherosclerosis is challenging. Else-
where, it has been shown, using data from the Whitehall
II study, that the mean progression rate of cIMT is esti-
mated to be 0.012 ± 0.028 mm per year [36]. Therefore,
the effects of consistent heavy drinking roughly equate
to 19 months expedited vascular ageing.
Measuring alcohol use over time is likely to be more
aetiologically relevant than a snap shot of alcohol at one
point in time. For example, it is reasonable to hypothe-
sise that sustained high levels of drinking increase the
formulation of atheromas on the vessel wall over time
[23, 24].
A major strength of this study is our ability to use re-
peated measures of alcohol consumption on the same
individuals over two decades before the measurement of
Fig. 2 Meta-analysis of difference in carotid intima media thickness (mm) by 20-year trajectories of alcohol consumption (reference stable moderate
drinkers). Multivariables adjusted = age, sex, ethnicity (in Whitehall II), socioeconomic position and smoking status
Fig. 1 Meta-analysis of the cross-sectional difference in carotid intima media thickness (mm) by current alcohol consumption category (reference
group moderate drinkers). Multivariables adjusted = age, sex, ethnicity (in Whitehall II), socioeconomic position and smoking status
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cIMT. The derived trajectories have policy relevance as
they are defined by UK government guidelines [33].
Treating cIMT as a surrogate endpoint allowed for us to
investigate midlife drinking as a risk factor for early ath-
erosclerosis. This enabled us to determine how drinking
during this period might set the stage for the develop-
ment of CVD, before it is necessarily symptomatic.
Our study is limited in that alcohol consumption was
self-reported and therefore at risk of over and under-
reporting [37, 38]. We were only able to capture snap
shots of drinking over the past week/5 days and have as-
sumed that these are a general representation of levels
consumed over that period. This may introduce error,
but we utilised the repetition of these snap shops to
more accurately create trajectories than simple use of a
baseline measure. Our sample is made up of individuals
who have remained in an epidemiological study for de-
cades. This is a form of selection bias [39] and may
mean that our sample is no longer representative of the
original population from which it was drawn. We found
those remaining in the studies and attending clinical re-
search facilities to be a healthier subsample than those
who dropped out or who did not participate fully. Fur-
thermore, population-based studies do not capture the
extremes of drinking and therefore may be underpow-
ered to look at the effects of very heavy drinking. At the
time of cIMT measurement, the proportion drinking in
excess of guidelines was 19.3 % in Whitehall II (21.9 %
men and 12.8 % women) and 13.0 % in NSHD (17.8 %
men and 7.9 % women), which is considerably lower
than recent estimates from Health Survey for England
(31 % men and 20 % women aged 55–64 years) [40]. It
may be that NSHD, in particular, was underpowered to
detect effects among sustained heavy drinkers (who con-
stituted only 3.5 % of the sample). Furthermore, we were
unable to assess the effects of binge drinking as these
data were not adequately captured in both studies at that
time. Although we included several covariates in the
analysis, as with most observational studies, we cannot
rule out that possibility of residual confounding.
Future work should consider the progression of cIMT
[18] into older age and whether changes in atheroscler-
osis, and ultimately CHD cases, are affected by changes
in drinking levels. Furthermore, it would be interesting
to extend the work on pattern of consumption [24] to
see whether sustained ‘binge’ drinking confers an in-
creased risk of higher cIMT compared to regular heavy
drinking [41], as is found for CHD overall [42].
Conclusions
These findings indicate that the drinking habits adopted
by adults during midlife affect the atherosclerotic process,
and that sustained heavy drinking is associated with an in-
creased risk of poor cardiovascular health compared to
stable moderate drinkers. This finding was not seen when
using cross-sectional analyses only, thus highlighting the
importance of taking a longitudinal approach. Further-
more, there was no evidence of a favourable atheroscler-
otic profile among stable moderate drinkers compared to
non-drinkers.
Additional files
Additional file 1: Figure S1. Meta-analysis of current drinking separated
into “former drinker” and “never drinker” categories (reference moderate
drinkers). Figure S2 Derived trajectories of alcohol and difference in carotid
intima media thickness (cIMT, mm) in those with and without prevalent
CHD/diabetes in the Whitehall II study. (DOCX 428 KB)
Additional file 2: Table S1. Cross sectional differences in cIMT (mm) by
current alcohol consumption category (reference group moderate drinkers).
Full results from regression models Table S2: Meta-analysis of difference in
cIMT (mm) by 20 year trajectory of alcohol consumption (reference stable
moderate drinkers). Full results from regression models. (DOCX 16 KB)
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